Literature DB >> 1561819

Minimizing the side effects of antireflux surgery.

T R DeMeester1, H J Stein.   

Abstract

To address the durability and long-term side effects of the Nissen fundoplication as surgical therapy for gastroesophageal reflux disease, we evaluated 100 patients postoperatively. With careful attention to technical detail as described, the incidence of temporary postoperative dysphagia was 39% and permanent dysphagia was 3%. Effective relief of reflux symptoms over more than 10 years was achieved in 91% of the patients with minimal side effects.

Entities:  

Mesh:

Year:  1992        PMID: 1561819     DOI: 10.1007/bf02071542

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  3 in total

1.  Evaluation of current operations for the prevention of gastroesophageal reflux.

Authors:  T R Demeester; L F Johnson; A H Kent
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

2.  Intrathoracic fundoplication for shortened esophagus. Treacherous solution to a challenging problem.

Authors:  J D Richardson; G M Larson; H C Polk
Journal:  Am J Surg       Date:  1982-01       Impact factor: 2.565

3.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

  3 in total
  27 in total

1.  Five- to eight-year outcome of the first laparoscopic Nissen fundoplications.

Authors:  T Bammer; R A Hinder; A Klaus; P J Klingler
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

Review 2.  Complications of laparoscopic antireflux surgery.

Authors:  D I Watson; A C de Beaux
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

3.  Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis.

Authors:  R J Baigrie; D I Watson; J C Myers; G G Jamieson
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 4.  Laparoscopic Nissen fundoplication with or without short gastric vessel division: a meta-analysis.

Authors:  Kamran Khatri; Muhammad S Sajid; Robert Brodrick; Mirza K Baig; Mazin Sayegh; Krishna K Singh
Journal:  Surg Endosc       Date:  2011-11-01       Impact factor: 4.584

5.  Long-term outcome of laparoscopic antireflux surgery in the elderly.

Authors:  Olivier Brehant; Patrick Pessaux; Jean-Pierre Arnaud; Jean-François Delattre; Christian Meyer; Jacques Baulieux; Henri Mosnier
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

6.  Severely disordered esophageal peristalsis is not a contraindication to laparoscopic Nissen fundoplication.

Authors:  Y W Novitsky; J Wong; K W Kercher; D E M Litwin; L L Swanstrom; B T Heniford
Journal:  Surg Endosc       Date:  2006-12-20       Impact factor: 4.584

7.  Concurrent fluoroscopy and manometry reveal differences in laparoscopic Nissen and anterior fundoplication.

Authors:  J A Anderson; J C Myers; D I Watson; M Gabb; G Mathew; G G Jamieson
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

8.  Total fundoplication is the operation of choice for patients with gastroesophageal reflux and defective peristalsis.

Authors:  D Oleynikov; T R Eubanks; B K Oelschlager; C A Pellegrini
Journal:  Surg Endosc       Date:  2002-03-26       Impact factor: 4.584

9.  MRI patterns of Nissen fundoplication: normal appearance and mechanisms of failure.

Authors:  Christiane Kulinna-Cosentini; Wolfgang Schima; Ahmed Ba-Ssalamah; Enrico P Cosentini
Journal:  Eur Radiol       Date:  2014-06-26       Impact factor: 5.315

10.  Division of the short gastric vessels during laparoscopic Nissen fundoplication: clinical and functional outcome during long-term follow-up in a prospectively randomized trial.

Authors:  Volkan Kösek; Heinz Wykypiel; Helmut Weiss; Elisabeth Höller; Gerold Wetscher; Raimund Margreiter; Alexander Klaus
Journal:  Surg Endosc       Date:  2008-12-10       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.